Alamar Biosciences, Inc. (ALMR) stock
ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$30.64+0.09 (+0.29%)
Close on Nov 17, 2026Market cap $2.13BP/E –Yield –
Alamar Biosciences total assets
Total assets on the balance sheet at the end of each period.
Alamar Biosciences's total assets was $378.03M at Sep 30, 2026. For fiscal 2025 it was $139.99M.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $139.99M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $378.03M | – |
| Q2 FY2026 | Jun 30, 2026 | $390.98M | – |
| Q1 FY2026 | Mar 31, 2026 | $186.45M | – |
| Q4 FY2025 | Dec 31, 2025 | $139.99M | – |
See a number that looks wrong?